Related Experiment Video
Updated: May 22, 2026
07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned?
K El-Hayek1, P Timratana, H Shimizu
1Bariatric and Metabolic Institute, Cleveland Clinic, M61, 9500 Euclid Avenue, Cleveland, OH 44195, USA. elhayek@ccf.org
Surgical Endoscopy
|May 1, 2012
Summary
Marginal ulcers are common after Roux-en-Y gastric bypass (RYGB), with pain and dysphagia being key symptoms. Tobacco use is the only significant risk factor for recurrence, highlighting the need for cessation.
Area of Science:
- Bariatric Surgery
- Gastroenterology
- Surgical Complications
Background:
- The definition and diagnosis of marginal ulcers following Roux-en-Y gastric bypass (RYGB) lack consensus.
- Symptomatic patients undergoing upper endoscopy at a specialized bariatric center were evaluated.
- The study investigated presenting symptoms, causes, and treatment effectiveness for marginal ulcers.
Purpose of the Study:
- To define and characterize marginal ulcers after RYGB.
- To identify common symptoms, etiologies, and risk factors associated with marginal ulcers.
- To assess treatment efficacy and recurrence rates for marginal ulcers.
Main Methods:
- Retrospective review of upper gastrointestinal endoscopy findings in RYGB patients from June 2010 to August 2011.
- Analysis of a database from a quaternary bariatric referral center.
- Statistical analysis to identify risk factors for marginal ulcer development and recurrence.
Main Results:
- Marginal ulcers were diagnosed in 34% of 328 symptomatic patients.
- Common symptoms included pain, dysphagia, nausea, and vomiting.
- Tobacco use was the sole significant independent risk factor for ulcer recurrence (p=0.01).
Conclusions:
- Upper endoscopy is recommended for symptomatic RYGB patients due to high abnormality detection rates.
- Potential etiologies like tobacco, alcohol, and NSAID use require investigation and elimination.
- Tobacco use is a critical factor influencing ulcer persistence and recurrence after RYGB.
Related Concept Videos
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD: